Technology

Latest News


CME Content


In a recently published article, researchers from Yale University discuss the pros and cons of current FDA regulations as they apply to the clearance and use of adjunctive artificial intelligence (AI) software with conventional breast cancer screening modalities such as mammography.

While artificial intelligence (AI) models have been acknowledged for aiding imaging analysis or facilitating workflow enhancements, this author envisions AI as a potential workstation conceierge capable of turning common venting and gripes into actionable items for significant improvements.